Literature DB >> 640643

A comparative study of 14 cases of familial and nonfamilial pheochromocytomas.

R A Wilson, M L Ibanez.   

Abstract

A comparison is made between epidemiological features found in a group of 14 patients with familial and nonfamilial pheochromocytomas at M. D. Anderson Hospital and Tumor Institute. The Sipple syndrome (familial) group comprised eitht patients from three different families, and the nonfamilial group consisted of six nonrelated patients. The main differences were noted in the age of onset, sex ratio, bilaterality, malignant behavior, and occurrence of a second nonendocrine primary tumor. An attempt was made by light microscopy to define features that would indicate malignant behavior. No such features could be delineated. Survival time was unrelated to the presence of pheochromocytoma except in operative and investigative procedures.

Entities:  

Mesh:

Year:  1978        PMID: 640643     DOI: 10.1016/s0046-8177(78)80109-9

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  4 in total

1.  Phaeochromocytoma--investigation and management of 10 cases.

Authors:  J E Deal; P S Sever; T M Barratt; M J Dillon
Journal:  Arch Dis Child       Date:  1990-03       Impact factor: 3.791

2.  Bilateral pheochromocytomas.

Authors:  V Kalff; B Shapiro; R Lloyd; M Nakajo; J C Sisson; W H Beierwaltes
Journal:  J Endocrinol Invest       Date:  1984-08       Impact factor: 4.256

3.  Pheochromocytoma in von hippel-lindau disease: distinct histopathologic phenotype compared to pheochromocytoma in multiple endocrine neoplasia type 2.

Authors:  Christian A Koch; David Mauro; McClellan M Walther; W Marston Linehan; Alexander O Vortmeyer; Ronald Jaffe; Karel Pacak; George P Chrousos; Zhengping Zhuang; Irina A Lubensky
Journal:  Endocr Pathol       Date:  2002       Impact factor: 3.943

Review 4.  Von Hippel-Lindau Disease: Current Challenges and Future Prospects.

Authors:  Sven Gläsker; Evelynn Vergauwen; Christian A Koch; Alexander Kutikov; Alexander O Vortmeyer
Journal:  Onco Targets Ther       Date:  2020-06-16       Impact factor: 4.147

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.